Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Is a total bilirubin of 4.4 mg/dL markedly elevated despite normal AST, alkaline phosphatase, and albumin?

A total bilirubin of 4.4 mg/dL is a marked abnormality and warrants prompt clinical evaluation even when AST, alkaline phosphatase, and albumin are normal.

PlausibleSeptember 23, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

A total bilirubin of 4.4 mg/dL is markedly elevated in most adult laboratory ranges and warrants prompt clinical evaluation, even when alkaline phosphatase, albumin, and AST are normal.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim frames 4.4 mg/dL as clearly above typical adult bilirubin reference ranges and above the level where jaundice may become visible. The mechanism described is that this degree of elevation can still reflect clinically relevant bilirubin handling or obstruction even when other routine liver tests are normal, so fractionated bilirubin and cause-directed assessment are used to sort the pattern.

Verified conclusion

A total bilirubin of 4.4 mg/dL in a 77-year-old man is a substantial abnormality, even if AST, alkaline phosphatase, and albumin are normal. It is roughly 3–4 times typical adult upper reference limits (about 1.0–1.3 mg/dL) and exceeds the approximate 2.5–3 mg/dL range at which jaundice often becomes visible.

Clinical significance

  • A value of 4.4 mg/dL supports timely clinical assessment and confirmation, rather than dismissal as an isolated laboratory variation.
  • The reporting laboratory’s own reference interval remains the formal comparator, but this level is clearly elevated in most adult laboratory systems.
  • Normal AST, alkaline phosphatase, and albumin do not exclude clinically important causes of hyperbilirubinemia. Albumin alone also does not establish current hepatic synthetic function; PT/INR is relevant.

Mechanistic and diagnostic implications

  • Initial testing should repeat and fractionate bilirubin into direct (conjugated) and indirect (unconjugated) fractions, since this distinction directs the differential diagnosis.
  • Predominantly indirect elevation suggests impaired conjugation or increased bilirubin production; assessment commonly includes CBC, reticulocyte count, LDH, haptoglobin, peripheral smear, and medication review for hemolysis or drug effects. Gilbert syndrome can be considered only after appropriate exclusion of alternatives.
  • Predominantly direct elevation can reflect impaired bilirubin transport, medication effects, hepatocellular disease, or biliary obstruction, including presentations where routine enzymes are initially normal.

Urgency

  • Bilirubin of 4.4 mg/dL warrants prompt outpatient or acute clinical evaluation, but the number alone does not establish a need for emergency care.
  • Urgent/emergency assessment is appropriate with fever and right-upper-quadrant or severe abdominal pain, rapidly worsening jaundice, sepsis, confusion/encephalopathy, coagulopathy/prolonged INR, or other clinical deterioration.

Bottom line

  • A total bilirubin of 4.4 mg/dL is markedly elevated and merits timely fractionated-bilirubin and cause-directed evaluation despite normal AST, alkaline phosphatase, and albumin; symptom severity and associated findings determine whether care must be urgent or emergent.

References

  1. Reference intervals for common clinical chemistry parameters ... — pmc.ncbi.nlm.nih.gov ↗
  2. Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests — academic.oup.com ↗
  3. Determination of reference intervals for common liver function ... — pmc.ncbi.nlm.nih.gov ↗
  4. Bilirubin Pathways and Pitfalls: From Processing to Pathology - AASLD — aasld.org ↗
  5. ACG Practice Guideline: Evaluation of Abnormal Liver Chemistries — bpb-us-w2.wpmucdn.com ↗
  6. Evaluation of Jaundice in Adults | AFP — aafp.org ↗
  7. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries — acgcdn.gi.org ↗
  8. Isolated Elevated Bilirubin - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  9. Evaluating Elevated Bilirubin Levels in Asymptomatic Adults — pmc.ncbi.nlm.nih.gov ↗
  10. Jaundice - Hepatology - Merck Manual Professional Edition — merckmanuals.com ↗
  11. Laboratory Tests of the Liver and Gallbladder — merckmanuals.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesCan elevated total bilirubin be interpreted without direct and indirect fractions?→Plausible9 sourcesCan gut microbial beta-glucuronidase deconjugate biliary compounds and promote enterohepatic reabsorption?→